Target intelligence / Profile preview

Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 (APPL2)

Target
APPL2
Molecular classification
Adapter protein, Endosomal signaling effector, BAR (Bin/Amphiphysin/Rvs) domain protein, Signal transduction molecule, Other
01

Overview

Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 (APPL2) is a multifunctional adapter protein characterized by a BAR domain (important in membrane curvature sensing), a central PH domain, and a C-terminal phosphotyrosine-binding (PTB) domain[2]. It binds small GTPases, including Rab5, and interacts with various receptors and signaling proteins to regulate cellular processes such as endosomal trafficking, cell proliferation, F-actin remodeling, and signal transduction[1][2]. In pancreatic β-cells, APPL2 is a critical regulator of glucose-stimulated insulin secretion via modulation of Rac1-mediated actin depolymerization. APPL2 also plays roles in the immune response by influencing phagocytosis and inflammatory signaling pathways, and negatively regulates adiponectin signaling and insulin sensitivity in metabolic tissues[1][2][3]. Genetic alterations or dysregulation of APPL2 activity have been linked to metabolic disorders and rare syndromic diseases, but APPL2 itself is not considered a direct pharmacological target[1][2][3].

Other names
DCC-interacting protein 13-betaDIP13BDip13-betaFLJ10659Adapter protein containing PH domain, PTB domain and leucine zipper motif 2DCC-interacting protein 13 betaadaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2
02

Biological functions

Cell proliferationSignal transductionEndosomal traffickingRegulation of glucose-stimulated insulin secretionImmune response modulationF-actin cytoskeletal remodelingCell metabolismApoptosis
03

Disease associations

Type 2 diabetes (contribution to dysfunctional insulin secretion)Immune/inflammatory disorders (via modulation of NF-κB and inflammatory cytokines)Phelan-McDermid syndrome (by chromosomal rearrangement)Nonalcoholic fatty liver disease (implicated by genetic association)Other (cell proliferation, tumorigenesis—rare or indirect associations)

Beyond the preview

Go deeper on Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 (APPL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 (APPL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call